Corteva (NYSE:CTVA – Get Free Report) was downgraded by equities research analysts at Zacks Research from a “strong-buy” rating to a “hold” rating in a report released on Tuesday,Zacks.com reports.
Several other research firms also recently commented on CTVA. Barclays increased their price objective on Corteva from $84.00 to $91.00 and gave the company an “overweight” rating in a research note on Thursday, June 11th. Bank of America raised their price objective on Corteva from $90.00 to $96.00 and gave the stock a “buy” rating in a research report on Monday, July 20th. UBS Group upped their price target on Corteva from $86.00 to $89.00 and gave the stock a “neutral” rating in a research note on Monday, August 3rd. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $101.00 price objective on shares of Corteva in a report on Monday, August 3rd. Finally, Rothschild & Co Redburn increased their target price on Corteva from $80.00 to $90.00 and gave the stock a “neutral” rating in a research note on Wednesday, April 29th. Fourteen investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $91.70.
View Our Latest Stock Report on CTVA
Corteva Stock Down 0.9%
Corteva (NYSE:CTVA – Get Free Report) last posted its quarterly earnings data on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.24 by $0.06. The company had revenue of $6.38 billion for the quarter, compared to analysts’ expectations of $6.60 billion. Corteva had a return on equity of 10.18% and a net margin of 5.66%.Corteva’s revenue was down 1.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.20 EPS. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Equities analysts forecast that Corteva will post 3.72 earnings per share for the current fiscal year.
Institutional Trading of Corteva
Institutional investors and hedge funds have recently bought and sold shares of the business. Compass Financial Management LLC purchased a new stake in shares of Corteva in the second quarter valued at about $25,000. JPL Wealth Management LLC purchased a new stake in Corteva during the 3rd quarter valued at approximately $25,000. Garton & Associates Financial Advisors LLC acquired a new stake in Corteva during the 4th quarter worth approximately $27,000. Bank of Jackson Hole Trust purchased a new position in shares of Corteva in the 4th quarter valued at approximately $28,000. Finally, Cornerstone Financial Management LLC acquired a new position in shares of Corteva in the fourth quarter valued at approximately $29,000. Hedge funds and other institutional investors own 81.54% of the company’s stock.
About Corteva
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Read More
- Five stocks we like better than Corteva
- Franco-Nevada Earnings: Gold Is Rallying, But Does the Stock Even Care?
- GE Vernova’s AI Power Boom Faces a Profit Test
- Cardinal Health Earnings: Can Perfection Get Priced In Twice?
- Nebius’ Q2 Beat Shows the AI Bottleneck Is Capacity, Not Demand
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
